Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis

医学 内科学 放射治疗 化疗 倾向得分匹配 卡培他滨 佐剂 子群分析 癌症 肿瘤科 阶段(地层学) 辅助治疗 多元分析 外科 胃肠病学 结直肠癌 置信区间 古生物学 生物
作者
Ravi Shridhar,Paige A. Blinn,Jamie Huston,Kenneth Lee Meredith
出处
期刊:Cancer [Wiley]
卷期号:129 (6): 890-900 被引量:10
标识
DOI:10.1002/cncr.34625
摘要

BACKGROUND: Adjuvant capecitabine is considered a standard of care for resected cholangiocarcinoma per the BILCAP trial. The role of adjuvant radiation therapy in that trial was not addressed. This study was designed to examine the outcomes of adjuvant radiation in patients who received chemotherapy for resected cholangiocarcinoma. METHODS: Using the National Cancer Database, the authors identified high-risk patients with resected extrahepatic cholangiocarcinoma with either positive nodes (N+) or margins (R1) who received adjuvant chemotherapy between 2006 and 2014. Overall survival (OS) was determined with the Kaplan-Meier method. Propensity score matching (PSM) and multivariate analysis (MVA) were performed to identify prognostic factors for survival. RESULTS: The authors identified 1478 patients after PSM who were included in the analysis. There was no difference in OS between patients receiving single-agent chemotherapy and patients receiving multiagent chemotherapy (p = .69). There was a significant OS benefit associated with radiation therapy. The median OS and the 5-year OS rate for radiated patients versus nonradiated patients were 34 months and 33% versus 27 months and 24% (p < .001) for the whole group, 30 months and 29% versus 24 months and 19% (p = .007) for the N+ subgroup, and 25 months and 23% versus 20 months and 12% (p = .03) for the R1 subgroup. MVA demonstrated that age, N stage, T stage, R1, and grade were associated with increased mortality, whereas adjuvant radiation was associated with decreased mortality (p < .001). CONCLUSIONS: This is the first study showing that adjuvant radiation therapy after chemotherapy resulted in a significant OS benefit for patients with resected high-risk extrahepatic cholangiocarcinoma. Trials are needed to address the role of radiation therapy in this population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风吹麦浪发布了新的文献求助10
刚刚
贤惠的夜南完成签到,获得积分10
1秒前
西贝发布了新的文献求助10
2秒前
CodeCraft的应助被111采纳,获得10
3秒前
刘玄德完成签到 ,获得积分10
3秒前
毛毛123完成签到,获得积分10
3秒前
3秒前
3秒前
4秒前
共享精神的应助被玩命的灵寒采纳,获得10
5秒前
xucc发布了新的文献求助10
5秒前
魔幻的飞鸟完成签到,获得积分10
5秒前
荼蘼发布了新的文献求助10
5秒前
6秒前
fantasy的应助被Eli采纳,获得10
6秒前
8秒前
123ggggg完成签到,获得积分10
8秒前
BAEKHYUNLUCKY发布了新的文献求助10
9秒前
乐空思的应助被茶茶采纳,获得20
9秒前
9秒前
jkjkjkjkhs发布了新的文献求助30
9秒前
Leemon33完成签到,获得积分10
9秒前
wanci的应助被苍焰流光斩采纳,获得10
9秒前
米酥完成签到,获得积分10
9秒前
熊加油完成签到,获得积分10
10秒前
DrMA完成签到,获得积分10
11秒前
辰的小猫完成签到 ,获得积分20
12秒前
111完成签到 ,获得积分10
12秒前
12秒前
心灵美诗霜完成签到,获得积分10
12秒前
13秒前
六碳烷完成签到,获得积分10
14秒前
荼蘼发布了新的文献求助10
15秒前
16秒前
teron完成签到,获得积分10
16秒前
Z1POKK完成签到,获得积分10
17秒前
无私绝音完成签到,获得积分10
17秒前
19秒前
20秒前
SDD完成签到,获得积分20
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566975
关于积分的说明 21789458
捐赠科研通 7769647
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241